Prof Peter-Phillip de Cruz
Professorial Fellow, Gastroenterology
Department of Medicine
384 Scholarly works
5 Projects
HIGHLIGHTS
2026
Journal article
Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn’s Disease Postoperative Recurrence in the PREVENT Trial
DOI: 10.1016/j.cgh.2025.08.0212026
Journal article
Access to intestinal ultrasound influences diagnostic decision-making, reduces healthcare costs and improves sustainability in inflammatory bowel disease
DOI: 10.1136/flgastro-2025-1035772024
Research grants (ARC, NHMRC, MRFF)
Mathematical and Computational Methods for Precision Medicine in Acute Severe Ulcerative Colitis
2022
Research grants (ARC, NHMRC, MRFF)
Improving Outcomes in Inflammatory Bowel Disease: A Multifaceted Program of Research
2021
Research grants (ARC, NHMRC, MRFF)
A Prospective Randomised Controlled Trial of Adults With Perianal Fistulising Crohn\2019s Disease and Optimised Therapeutic Infliximab Levels: PROACTIVE Trial
2016
Journal article
Intestinal Failure and Transplant: The Australian Experience (2009 to 2014)
DOI: 10.1016/j.transproceed.2015.09.0712015
Journal article
Crohn's disease management after intestinal resection: A randomised trial
DOI: 10.1016/S0140-6736(14)61908-5
RECENT SCHOLARLY WORKS
2026
Journal article
2026
Journal article
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC
DOI: 10.1053/j.gastro.2025.07.0202026
Journal article
Implementation of values-based healthcare in inflammatory bowel disease—a review
DOI: 10.1093/ecco-jcc/jjaf1732026
Journal article
P0372 Access to intestinal ultrasound reshapes diagnostic pathways and healthcare costs in Crohn’s disease and ulcerative colitis: analysis of clinician decision-making at the point of referral
DOI: 10.1093/ecco-jcc/jjaf231.5532026
Journal article
P0684 Rethinking the Dose: A Bayesian Meta-Analysis of Infliximab Intensification in Acute Severe Ulcerative Colitis
DOI: 10.1093/ecco-jcc/jjaf231.8652026
Journal article
P1096 Randomised controlled trial of continued intravenous versus switching to subcutaneous infliximab in inflammatory bowel disease: the Subcutaneous Infliximab Switch Study (SISS).
DOI: 10.1093/ecco-jcc/jjaf231.12772026
Journal article
Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency Department
DOI: 10.1007/s10620-026-09786-w2025
Journal article
Combination Advanced Therapies for Control of Ulcerative Colitis During Pregnancy
DOI: 10.14309/crj.0000000000001920